CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
manner the recurrence-free survival (RFS) of Stage IIIB/C/D melanoma patients with respect to the standard of care (surgery and adjuvant the...
Phase 3
Chicago, Illinois, United States and 36 other locations
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Chicago, Illinois, United States and 71 other locations
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Park Ridge, Illinois, United States and 100 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Chicago, Illinois, United States and 67 other locations
use the immune system to recognize and kill cancer cells. The study is focused on participants with a type of skin cancer known as melanoma...
Phase 2
Evanston, Illinois, United States and 53 other locations
To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...
Phase 2
Chicago, Illinois, United States and 56 other locations
treatment of adult subjects with completely treated high-risk ocular melanoma, as defined in eligibility criteria, without evidence of metas...
Phase 2
Chicago, Illinois, United States and 5 other locations
condition of metastatic (spread to other parts of your body) uveal melanoma. This research study will test the study drugs to see if the com...
Phase 2
Chicago, Illinois, United States and 3 other locations
of nivolumab and ipilimumab in patients with metastatic uveal melanoma who have not been treated with immune checkpoint inhibitor therapy....
Phase 2, Phase 3
Chicago, Illinois, United States and 27 other locations
and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...
Phase 3
Chicago, Illinois, United States and 130 other locations
Clinical trials
Research sites
Resources
Legal